The Role of Imaging in Multiple Sclerosis

Seaman WB Ter-Pogossian MM Schwartz HG : Localization of intracranial neoplasms with radioactive isotopes. Radiology 62: 30–36, 1954.

Antunes JL Schlesinger EB Michelsen WJ : The abnormal brain scan in demyelinating diseases. Archives of Neurology 30: 269–271, 1974.

Cohan SL Fermaglich J Auth TL : Abnormal brain scans in multiple sclerosis. Journal of Neurology, Neurosurgery and Psychiatry 38: 120–122, 1975.

Moseley IF : Imaging techniques. In: Neetens A Lowenthal A Martin JJ (eds): The visual system in myelin disorders. Bulletin de la Société Beige d'Ophtalmologie 208-I: 237–259, 1983.

Gyldensted C : Computer tomography of the cerebrum in multiple sclerosis. Neuroradiology 12: 33–42, 1976.

Radue EW Kendall BE : Iodide and xenon enhancement of computed tomography in multiple sclerosis. Neuroradiology 15: 153–158, 1978.

Young IR Hall AS : Nuclear magnetic resonance imaging of the brain in multiple sclerosis. Lancet ii: 1063–106, 1981.

Asbury AK Herndon RM : National Multiple Sclerosis Society Working Group on Neuroimaging for the Medical Advisory Board. Policy statement. Use of magnetic resonance imaging in the diagnosis of multiple sclerosis. Neuroradiology 29: 119, 1987.

Kline LB : Gadolinium-DPTA-enhanced magnetic resonance imaging in optic neuropathies (discussion). Ophthalmology 97: 599–600, 1990.

Rizzo JF Lessell S : Optic neuritis and ischemic optic neuropathy. Overlapping clinical profiles. Archives of Ophthalmology 109: 1668–1672, 1991.

Moseley IF : Diagnostic imaging in visual loss: A problem-orientated approach. Imaging 4: 151–155.

Ormerod IEC Miller DH : The role of NMR imaging in the assessment of multiple sclerosis and isolated neurological lesions. A quantitative study. Brain 110: 1579–1616, 1987.

Fazekas F Offenbacher H : Criteria for an increased specificity of MRI interpretation in elderly subjects with suspected multiple sclerosis. Neurology 38: 1822–1825, 1988.

Thorpe JW Kidd D : Spinal MRI in patients with suspected multiple sclerosis and negative brain MRI. Brain 119: 709–714, 1996.

Paty DW Oger JJF : Magnetic resonance imaging in the diagnosis of multiple sclerosis (MS): A prospective study of comparison with clinical evaluation, evoked potentials, oligoclonal banding, and CT. Neurology 38: 180–185, 1988.

Barkhof F Filippi M : Comparison of MR imaging criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain 120: 2059–2069, 1997.

Triulzi F Scotti G : Differential diagnosis of multiple sclerosis: Contribution of magnetic resonance techniques. Journal of Neurology, Neurosurgery and Psychiatry 64 (Suppl): S6–S14, 1998.

Zajicek JP Scolding NJ : Central nervous system sarcoidosis — Diagnosis and management. Quarterly Journal of Medicine 92: 103–117, 1999.

Wise CM Agudelo CA : Optic neuropathy as an initial manifestation of Sjögren's syndrome. Journal of Rheumatology 15: 799–802, 1988.

Harada T Ohashi T : Optic neuropathy and acute transverse myelopathy in primary Sjögren's syndrome. Japanese Journal of Ophthalmology 39: 162–165, 1995.

George AE de Leon MJ : Leukoencephalopathy in normal and pathologic aging. Am J Neuroradiol 7: 567–570, 1986.

Caldemeyer KS Smith RR : MRI in acute disseminated encephalomyelitis. Neuroradiology 36: 212–220, 1994.

Kesselring J Miller DH : Acute disseminated encephalomyelitis. MRI findings and the distinction from multiple sclerosis. Brain 113: 291–302, 1990.

Thompson AJ Kermode AG : Patterns of disease activity in multiple sclerosis: Clinical and magnetic resonance imaging study. British Medical Journal 300: 631–634, 1990.

Moseley IF Gass A Miller DH : The contribution of magnetic resonance imaging to the assessment of optic nerve and spinal cord involvement in multiple sclerosis. Journal of Neurology, Neurosurgery and Psychiatry 64 (Suppl): S15–S20, 1998.

Miller DH Ormerod IEC : The early risk of multiple sclerosis after optic neuritis. Journal of Neurology, Neurosurgery and Psychiatry 51: 1569–1571, 1988.

Morrissey SP Miller DH : The significance of brain magnetic resonance imaging abnormalities at presentation with clinically isolated syndromes suggestive of multiple sclerosis. A five-year follow-up study. Brain 116: 135–146, 1993.

Söderström M : The clinical and paraclinical profile of multiple sclerosis: A prospective study. Italian Journal of Neurological Sciences 16: 167–176, 1995.

Sandberg-Wollheim M Bynke H : A long-tern study of optic neuritis: Evaluation of risk factors. Annals of Neurology 27: 386–393, 1990.

Kermode AG Tofts PS : The natural history of the multiple sclerosis lesion. Journal of Neurology, Neurosurgery and Psychiatry 52: 1205–1205, 1989.

Thompson AJ Kermode AG : Seizures due to multiple sclerosis: Seven patients with MRI correlations. Journal of Neurology, Neurosurgery and Psychiatry 56: 1317–1320, 1993.

van der Velden M Bots G : Cranial CT in multiple sclerosis showing a mass effect. Surgical Neurology 12: 307–310, 1979.

Dagher AP Smirniotopoulos J : Tumefactive demyelinating lesions. Neuroradiology 38: 560–565, 1996.

Moore V : Regents of the University of California. 51Cal3d 120, 1990.

Edan G Miller D : Therapeutic effect of mitoxantrone combined with methylprednisolone in multiple sclerosis: A randomised multicentre study of active disease using MRI and clinical criteria. Journal of Neurology, Neurosurgery and Psychiatry 62: 112–118, 1997.

INFB Multiple Sclerosis Study Group : Interferon beta-7b is effective in relapsing and remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind-placebo controlled trial. Neurology 43: 662–667, 1993.

Thorpe JW Halpin SF : A comparison between fast and conventional spin-echo in the detection of multiple sclerosis lesions. Neuroradiology 36: 388–392, 1994.

Gawne-Cain ML O'Riordan JI : Multiple sclerosis lesion detection in the brain: A comparison of fast fluid-attenuated inversion recovery and conventional T2-weight-ed dual spin echo. Neurology 49: 364–370, 1997.

Molyneux PD Wang L : Quantitative techniques for lesion load measurement in multiple sclerosis: A validation study of the global threshold technique after nonuniformity and histogram matching corrections. European Journal of Neurology 4: 1–6, 1997.

Silver NC Good CD : Sensitivity of contrast enhanced MRI in multiple sclerosis. Effects of gadolinium dose, magnetization transfer contrast and delayed imaging. Brain 120: 1149–1161, 1997.

Barkhof F McGowan JC : Hypointense multiple sclerosis lesions on T1-weighted spin echo magnetic resonance images: Their contribution in understanding multiple sclerosis evolution. Journal of Neurology, Neurosurgery and Psychiatry 64 (Suppl): S77–S79, 1988.

Filippi M : The role of non-conventional magnetic resonance techniques in monitoring evolution of multiple sclerosis. Journal of Neurology, Neurosurgery and Psychiatry 64 (Suppl): S52–S58, 1998.

Gass A Barker GJ : Correlation of magnetization transfer ratio with clinical disability in multiple sclerosis. Annals of Neurology 36: 62–67, 1994.

McGowan JC Filippi M : Magnetisation transfer imaging: Theory and application to multiple sclerosis. Journal of Neurology, Neurosurgery and Psychiatry 64 (Suppl): S66–S69, 1998.

Scott M : Atrophy of the parietal and cerebellar lobes associated in certain cases with multiple sclerosis. Archives of Neurology and Psychiatry 38: 218–222, 1937.

Delouvrier JJ Trischler JL : Computerized tomography in multiple sclerosis. In: Wackenheim A du Boulay GH (eds): Choices and characteristics in computerized tomography Kugler, Amsterdam 1980: 81–91.

Fox NC Freeborough PA Rossor MN : Visualisation and quantification of rates of atrophy in Alzheimer's disease. Lancet 348: 94–97, 1996.

Losseff NA Wang L : Progressive cerebral atrophy in multiple sclerosis: A serial MRI study. Brain 119: 2009–2019, 1996.

Kidd D Thorpe JW : Spinal cord MRI using multiarray coils and fast spin echo. II. Findings in multiple sclerosis. Neurology 43: 2632–2637, 1993.

Filippi M Colombo B : A longitudinal magnetic resonance imaging study of the spinal cord in multiple sclerosis. Journal of Neuroimaging 7: 78–80, 1997.